License Medical participated in the 'IMCAS World Congress 2025', a large-scale aesthetic plastic surgery conference held at Palais de Congrès in Paris, France from January 30 to February 1, and showcased its technological prowess.
At this three-day event, License Medical’s TargetCool booth received a lot of attention from medical professionals and dealers from all over the world, including Europe, Central and South America, Asia, Africa, and the Middle East. IMCAS is a prestigious academic society where medical aesthetics professionals from all over the world gather, and License Medical focused on introducing TargetCool’s cutting-edge technology and usability through this exhibition.
TargetCool is a non-contact, non-invasive skin beauty medical device that uses rapid precision cooling technology. It provides excellent effects in skin disease treatment and beauty treatments, and boasts the advantage of maximizing patient satisfaction with natural treatment and improvement effects. TargetCool quickly and precisely controls skin surface temperature to provide optimized solutions for various skin beauty treatments, and has been evaluated as innovative in that it supports three modes, allowing multiple treatments with a single device. In addition, a space was set up during the exhibition period where visitors could experience the product directly, and differentiated skin beauty solutions were presented to visitors, and it received a great response by implementing comfortable treatments and effective drug delivery systems.
During the exhibition period, License Medical expanded its global collaboration opportunities by signing new exclusive supply contracts with several countries including Israel, Poland, Kazakhstan, and Mexico. Through this, it is expected to strengthen partnerships with medical institutions in each country and further solidify the potential for future market growth.
On January 29th, the day before the opening of the exhibition, the global partners meeting, **'TargetCool Together Paris 2025'**, was held at the 'Méliá Paris La Defense Hotel' in Paris. Approximately 40 partners from around the world, including the UK, Hungary, Romania, Colombia, Costa Rica, Brazil, Thailand, and Malaysia, attended and shared their respective clinical and sales strategies and discussed ways to utilize products. Through this meeting, License Medical reaffirmed trust with existing and new partners and created an opportunity to further strengthen cooperation.
A License Medical official said, “IMCAS 2025 is very meaningful in that Target Cool received a lot of attention from the global market,” and “Based on the positive response we received from this exhibition, we plan to actively pursue sales expansion and collaboration opportunities in the global market.”
You must be logged in to post a comment.